Objective: To examine the prognostic value of different comorbidity coding schemes for predicting survival of newly diagnosed elderly cancer patients. Materials and methods: We analyzed data from 8867 patients aged 65 years of age or older, newly diagnosed with cancer. Comorbidities present at the time of diagnosis were collected using the Adult Comorbidity Evaluation-27 index (ACE-27). We examined multiple scoring schemes based on the individual comorbidity ailments, and their severity rating. Harrell's c index and Akaike Information Criterion (AIC) were used to evaluate the performance of the different comorbidity models. Results: Comorbidity led to an increase in c index from 0.771 for the base model to 0.782 for a model that included in...
Current common comorbidity measures have poor to moderate predictive validity of mortality of commun...
Yngvar Nilssen,1 Trond-Eirik Strand,1 Robert Wiik,2 Inger Johanne Bakken,3 Xue Qin Yu,4,5 Dianne L O...
Abstract Background Uncertainty regarding comorbid illness, and ability to tolerate aggressive thera...
Background: Individualized treatment in older patients with breast cancer can be improved by includi...
BACKGROUND: Prostate cancer management involves a balance between the risks of cancer death against ...
PurposeComorbidity is an independent predictor of mortality and treatment tolerance in head and neck...
Objectives: The comprehensive geriatric assessment (CGA) can detect geriatric problems and potential...
Background: Comorbidity has an important impact on cancer outcomes, but the optimal approach to meas...
Age is a dominant predictor of outcome in acute myeloid leukemia (AML). However, it is not clear to ...
Multiple myeloma occurs primarily in elderly patients. Considering the high prevalence of comorbidit...
OBJECTIVE: The negative impact of comorbidity on survival in women with endometrial carcinoma (EC) i...
OBJECTIVE: The negative impact of comorbidity on survival in women with endometrial carcinoma (EC) i...
PURPOSE: We investigated the long-term prognostic impact of age-adjusted Charlson comorbidity index ...
Comorbidities may affect survival and choice of treatment among cancer patients. In fact, comorbidit...
BACKGROUND: Morbidity, defined as disease history, is an important and well-known confounder in epid...
Current common comorbidity measures have poor to moderate predictive validity of mortality of commun...
Yngvar Nilssen,1 Trond-Eirik Strand,1 Robert Wiik,2 Inger Johanne Bakken,3 Xue Qin Yu,4,5 Dianne L O...
Abstract Background Uncertainty regarding comorbid illness, and ability to tolerate aggressive thera...
Background: Individualized treatment in older patients with breast cancer can be improved by includi...
BACKGROUND: Prostate cancer management involves a balance between the risks of cancer death against ...
PurposeComorbidity is an independent predictor of mortality and treatment tolerance in head and neck...
Objectives: The comprehensive geriatric assessment (CGA) can detect geriatric problems and potential...
Background: Comorbidity has an important impact on cancer outcomes, but the optimal approach to meas...
Age is a dominant predictor of outcome in acute myeloid leukemia (AML). However, it is not clear to ...
Multiple myeloma occurs primarily in elderly patients. Considering the high prevalence of comorbidit...
OBJECTIVE: The negative impact of comorbidity on survival in women with endometrial carcinoma (EC) i...
OBJECTIVE: The negative impact of comorbidity on survival in women with endometrial carcinoma (EC) i...
PURPOSE: We investigated the long-term prognostic impact of age-adjusted Charlson comorbidity index ...
Comorbidities may affect survival and choice of treatment among cancer patients. In fact, comorbidit...
BACKGROUND: Morbidity, defined as disease history, is an important and well-known confounder in epid...
Current common comorbidity measures have poor to moderate predictive validity of mortality of commun...
Yngvar Nilssen,1 Trond-Eirik Strand,1 Robert Wiik,2 Inger Johanne Bakken,3 Xue Qin Yu,4,5 Dianne L O...
Abstract Background Uncertainty regarding comorbid illness, and ability to tolerate aggressive thera...